SCHEDULE 13G/A

ArriVent Biopharma Inc

Common Stock, $0.0001 Par Value per Share · CUSIP: 04272N102

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Sofinnova Venture Partners XI, L.P. ("SVP XI")

  Shares: 1,696,752.00 · Class: 4.1%

• Sofinnova Management XI, L.P. ("SM XI LP")

  Shares: 1,696,752.00 · Class: 4.1%

• Sofinnova Management XI, L.L.C. ("SM XI LLC")

  Shares: 1,696,752.00 · Class: 4.1%

• Dr. James I. Healy ("Healy")

  Shares: 1,696,752.00 · Class: 4.1%

• Dr. Maha Katabi ("Katabi")

  Shares: 1,696,752.00 · Class: 4.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.